"Association of Quality of Life with Anticoagulant Control in Patients with Heart Failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial." by Jonathan A Shaffer

Selected Works of Ronald S. Freudenberger, MD, MBA

Article

Association of Quality of Life with Anticoagulant Control in Patients with Heart Failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.

International Journal of Cardiology

Jonathan A Shaffer
John L P Thompson, PhD
Bin Cheng
Siqin Ye
Gregory Y H Lip, MD
Douglas L Mann, MD
Ralph L Sacco, MD, MS
Patrick M Pullicino, MD
Ronald S Freudenberger, MD, Lehigh Valley Health Network
Susan Graham, MD
Jay P Mohr, MD
Arthur J Labovitz, MD
Conrado J Estol, MD, PhD
Dirk J Lok, MD
Piotr Ponikowski, MD, PhD
Stefan D Anker, MD, PhD
Marco R Di Tullio, MD
Shunichi Homma, MD

Link Find in your library

Publication/Presentation Date

12-15-2014

Disciplines

PubMedID

25456692

LVHN link

http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=25456692&site=ehost-live&scope=site

Document Type

Article

Citation Information

Shaffer, J. A., Thompson, J. P., Cheng, B., Ye, S., Lip, G. H., Mann, D. L., & ... Homma, S. (2014). Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. International Journal Of Cardiology, 177(2), 715-717. doi:10.1016/j.ijcard.2014.10.012